Kansas pill bill would hurt healthcare consumers, businesses | Opinion
Kansas manufacturers are used to managing costs we can’t control — raw materials, supply chain disruptions, global competition, and increasing tariffs.
But there’s one cost that keeps rising year after year and increasingly threatens our ability to invest, hire, and grow: healthcare.
Now, Kansas lawmakers are considering legislation — Senate Bill 360 — that would make the problem worse by imposing a new “pill tax” and government price controls on prescription drugs in the commercial insurance market.
While the bill is being discussed under the banner of “accountability,” its real-world impact would be simple and painful: higher prescription drug costs for Kansas employers, employees, and their families.
Integrated Components is a Wichita-based manufacturer that machines high-quality parts for customers across industries, including aerospace.
Like many Kansas employers, we offer health insurance because it’s the right thing to do — and because attracting and retaining skilled workers depends on it. But every additional mandate and artificial cost layered into the healthcare system makes that commitment harder to sustain.
At the center of this proposal is a requirement that pharmacies be reimbursed at least the national average drug acquisition cost plus a mandated dispensing fee of $10.50 for prescriptions.
That may not sound like much at the pharmacy counter, but across millions of prescriptions, it adds up fast.
This isn’t theory. Research shows that if a $10.50 dispensing fee were imposed nationwide in the commercial market, prescription drug spending would increase by nearly $16 billion in a single year.
Those dollars don’t come from thin air. They come directly from employer-sponsored health plans—and ultimately from workers’ paychecks and family budgets.
Supporters argue that SB 360 is needed to help pharmacies.
But mandating a one-size-fits-all fee is not reform, it’s a guaranteed price increase written into law.
In most markets today, dispensing fees and reimbursement rates are negotiated between pharmacies and health plans.
That negotiation allows flexibility, competition, and cost discipline.
A state-mandated fee replaces all of that with a government-set floor that guarantees higher spending regardless of efficiency or outcomes.
We’ve already seen what happens when states go down this road.
In 2022, West Virginia enacted a similar law requiring reimbursement at national average drug costs plus a mandated dispensing fee.
The result? An estimated $113 million increase in prescription drug spending in just one year — paid by employers and patients.
Kansas should take that lesson seriously.
The timing could not be worse.
Prescription drugs already account for a growing share of healthcare costs — nearly one-fourth of all commercial health spending.
Employers are struggling to keep up with premium increases, and many workers are seeing higher payroll deductions and out-of-pocket costs as a result.
Adding a pill tax on top of an already strained system will only accelerate that trend.
For manufacturers, this matters.
Rising healthcare costs crowd out wage growth, capital investment, and job creation.
They make it harder for Kansas companies to compete with firms in other states and countries that don’t face the same cost burdens. And they put more pressure on families who are already stretching their budgets to cover groceries, housing, and childcare.
Kansas lawmakers should be clear-eyed about who pays for this policy.
It’s not insurance companies. It’s not the state budget. It’s employers trying to do right by their workers—and employees picking up prescriptions for their kids, spouses, and parents.
We all want affordable, accessible healthcare. But price controls and pill taxes are not the answer. They increase costs, reduce flexibility, and lock in higher spending with no guarantee of better outcomes.
Kansas should focus on policies that lower healthcare costs, not ones that make them worse. Our employers, workers, and families deserve nothing less.
— Joshua Shorter is chief operating officer at Integrated Components.
This story was originally published February 17, 2026 at 5:15 AM.